Four integrated technologies for Biologics developability assessment

December 13, 2022

The decisions you make about your biologics candidates early in the pipeline ultimately affect their success as therapeutics.

Combine sizing and stability information to gain valuable insight into the viability of your protein-based biologic candidates, enabling you to select the best ones for further development.

The technologies inside the Prometheus Panta provide high-quality information about your candidates’ purity, size, thermal stability, and aggregation, which enables better pipeline decisions.

Learn more about how Prometheus Panta helps biologics researchers.

Previous Video
Screening for p38 ligands: From assay optimization to lead validation in 2 days
Screening for p38 ligands: From assay optimization to lead validation in 2 days

Dianthus is a biophysical screening instrument that uses Spectral Shift technology to measure molecular int...

Up next
Introducing Monolith X - the only way to get binding affinities in solution using very minimal sample
Introducing Monolith X - the only way to get binding affinities in solution using very minimal sample